title: Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.
abstract: The conjugation of siRNA to molecules, which can be internalized into the cell via natural transport mechanisms, can result in the enhancement of siRNA cellular uptake. Herein, the carrier-free cellular uptake of nuclease-resistant anti-MDR1 siRNA equipped with lipophilic residues (cholesterol, lithocholic acid, oleyl alcohol and litocholic acid oleylamide) attached to the 5'-end of the sense strand via oligomethylene linker of various length was investigated. A convenient combination of H-phosphonate and phosphoramidite methods was developed for the synthesis of 5'-lipophilic conjugates of siRNAs. It was found that lipophilic siRNA are able to effectively penetrate into HEK293, HepG2 and KB-8-5 cancer cells when used in a micromolar concentration range. The efficiency of the uptake is dependent upon the type of lipophilic moiety, the length of the linker between the moiety and the siRNA and cell type. Among all the conjugates tested, the cholesterol-conjugated siRNAs with linkers containing from 6 to 10 carbon atoms demonstrate the optimal uptake and gene silencing properties: the shortening of the linker reduces the efficiency of the cellular uptake of siRNA conjugates, whereas the lengthening of the linker facilitates the uptake but retards the gene silencing effect and decreases the efficiency of the silencing.
authors.affiliation: Laboratory of Nucleic Acids Biochemistry, Institute of Chemical Biology and Fundamental Medicine, SB RAS, Lavrentiev ave., 8, Novosibirsk 630090, Russia.
authors.forename: Natalya S
authors.initials: NS
authors.lastname: Petrova
authors.forename: Ivan V
authors.initials: IV
authors.lastname: Chernikov
authors.forename: Mariya I
authors.initials: MI
authors.lastname: Meschaninova
authors.forename: Iiya S
authors.initials: IS
authors.lastname: Dovydenko
authors.forename: Aliya G
authors.initials: AG
authors.lastname: Venyaminova
authors.forename: Marina A
authors.initials: MA
authors.lastname: Zenkova
authors.forename: Valentin V
authors.initials: VV
authors.lastname: Vlassov
authors.forename: Elena L
authors.initials: EL
authors.lastname: Chernolovskaya
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics; D001692:Biological Transport; D045744:Cell Line, Tumor; D002784:Cholesterol / Q000737:chemistry; D019008:Drug Resistance, Neoplasm; D057809:HEK293 Cells; D006801:Humans; D007700:Kinetics; D010641:Phenotype; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D034741:RNA, Small Interfering; D002784:Cholesterol
references.citation: Bioorg Med Chem Lett. 2004 Oct 4;14(19):4975-7
references.pmid: 15341962
references.citation: Science. 2003 Sep 12;301(5639):1545-7
references.pmid: 12970568
references.citation: Gene Ther. 2004 Oct;11 Suppl 1:S10-7
references.pmid: 15454952
references.citation: Nature. 2001 May 24;411(6836):494-8
references.pmid: 11373684
references.citation: Mol Biol (Mosk). 2010 Mar-Apr;44(2):284-93
references.pmid: 20586189
references.citation: Biochemistry. 1991 Mar 5;30(9):2439-44
references.pmid: 1705817
references.citation: Curr Protein Pept Sci. 2002 Oct;3(5):485-501
references.pmid: 12369997
references.citation: Nat Biotechnol. 2006 Aug;24(8):1005-15
references.pmid: 16823371
references.citation: RNA. 2003 Sep;9(9):1034-48
references.pmid: 12923253
references.citation: Arteriosclerosis. 1990 Jul-Aug;10(4):582-90
references.pmid: 2369367
references.citation: Nanomedicine (Lond). 2010 Oct;5(8):1219-36
references.pmid: 21039199
references.citation: J BUON. 2009 Sep;14 Suppl 1:S43-9
references.pmid: 19785069
references.citation: FEBS Lett. 2004 Jan 30;558(1-3):63-8
references.pmid: 14759517
references.citation: Nature. 2000 Mar 16;404(6775):293-6
references.pmid: 10749213
references.citation: Nucleic Acids Res. 2006 Jun 01;34(10):e73
references.pmid: 16740739
references.citation: RNA. 2007 Apr;13(4):431-56
references.pmid: 17329355
references.citation: Nat Biotechnol. 2009 Sep;27(9):839-49
references.pmid: 19701187
references.citation: Curr Opin Pharmacol. 2010 Oct;10(5):534-42
references.pmid: 20620113
references.citation: Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1048-52
references.pmid: 8430072
references.citation: Bioconjug Chem. 2009 Jan;20(1):5-14
references.pmid: 19053311
references.citation: Biochem J. 2007 Feb 15;402(1):117-24
references.pmid: 17034364
references.citation: Mol Pharm. 2009 May-Jun;6(3):747-51
references.pmid: 19093871
references.citation: FEBS J. 2010 Dec;277(23):4814-27
references.pmid: 21078116
references.citation: Curr Protoc Nucleic Acid Chem. 2001 May;Chapter 3:Unit 3.6
references.pmid: 18428846
references.citation: Trends Biotechnol. 2010 Nov;28(11):570-9
references.pmid: 20833440
references.citation: Nature. 2004 Nov 11;432(7014):173-8
references.pmid: 15538359
references.citation: Nucleic Acids Res. 2005 Nov 30;33(21):6837-49
references.pmid: 16321967
references.citation: Crit Rev Clin Lab Sci. 2002 Apr;39(2):89-137
references.pmid: 12014529
references.citation: Cancer Res. 1987 Feb 15;47(4):943-6
references.pmid: 3802101
references.citation: Nucleic Acids Res. 1992 Jul 11;20(13):3411-7
references.pmid: 1630912
references.citation: Nat Med. 2003 Mar;9(3):347-51
references.pmid: 12579197
references.citation: Oligonucleotides. 2009 Jun;19(2):191-202
references.pmid: 19344210
references.citation: Methods Mol Biol. 2007;361:217-26
references.pmid: 17172714
references.citation: Gene Ther. 2005 Jul;12(14):1089-98
references.pmid: 16003340
references.citation: J Clin Invest. 2000 Oct;106(8):923-8
references.pmid: 11032850
references.citation: Cell. 1997 May 2;89(3):331-40
references.pmid: 9150132
references.citation: Eur J Clin Invest. 2011 Feb;41(2):221-32
references.pmid: 20964680
references.citation: Mol Ther. 2008 Apr;16(4):734-40
references.pmid: 18362929
references.citation: J Cell Sci. 2010 Apr 15;123(Pt 8):1183-9
references.pmid: 20356929
references.citation: Nucleic Acids Res. 2006;34(16):4486-94
references.pmid: 16945951
references.citation: Nat Rev Drug Discov. 2004 Apr;3(4):318-29
references.pmid: 15060527
references.citation: Cell. 2000 Mar 31;101(1):25-33
references.pmid: 10778853
references.citation: Nat Rev Drug Discov. 2007 Jun;6(6):443-53
references.pmid: 17541417
references.citation: Biochim Biophys Acta. 1995 May 4;1235(2):289-95
references.pmid: 7756337
references.citation: Bioconjug Chem. 2007 Sep-Oct;18(5):1450-9
references.pmid: 17711319
references.citation: J Biol Chem. 1977 Jan 25;252(2):744-54
references.pmid: 188825
references.citation: Drugs Future. 2009 Sep;34(9):721
references.pmid: 20161621
references.citation: Nat Biotechnol. 2007 Oct;25(10):1149-57
references.pmid: 17873866
references.citation: Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(6-7):861-6
references.pmid: 15560073
references.citation: Nat Biotechnol. 2005 Jun;23(6):709-17
references.pmid: 15908939
references.citation: Adv Drug Deliv Rev. 2009 Jul 25;61(9):704-9
references.pmid: 19383521
references.citation: Handb Exp Pharmacol. 2005;(170):465-82
references.pmid: 16596811
references.citation: Biochim Biophys Acta. 1976 Nov 11;455(1):152-62
references.pmid: 990323
references.citation: Biochemistry. 1988 Oct 4;27(20):7607-13
references.pmid: 2905169
references.citation: Nature. 2002 Nov 14;420(6912):116-8
references.pmid: 12432357
references.citation: Biochem J. 1987 Nov 1;247(3):739-46
references.pmid: 3426559
references.citation: Chem Biol. 2004 Aug;11(8):1165-75
references.pmid: 15324818
references.citation: Cancer Res. 2008 Mar 1;68(5):1247-50
references.pmid: 18316585
references.citation: Science. 2003 Jan 24;299(5606):495
references.pmid: 12543948
references.citation: Nucleic Acids Res. 2005 Jan 07;33(1):27-42
references.pmid: 15640444
references.citation: Bioconjug Chem. 1998 May-Jun;9(3):341-9
references.pmid: 9576808
references.citation: Ann N Y Acad Sci. 2009 Sep;1175:32-9
references.pmid: 19796075
references.citation: J Clin Oncol. 1989 Apr;7(4):409-11
references.pmid: 2564427
references.citation: Nucleic Acids Res. 1996 Nov 15;24(22):4535-42
references.pmid: 8948646
references.citation: Biochim Biophys Acta. 2006 Mar;1758(3):290-300
references.pmid: 16337923
references.citation: J Control Release. 2006 Aug 10;114(1):100-9
references.pmid: 16831482
references.citation: Expert Opin Drug Deliv. 2010 Dec;7(12):1373-85
references.pmid: 21073358